Stocks · News reference
SCIENTURE To Provide REZENOPY To Addiction Treatment Centers
Agreement provides dedicated commercial channel for REZENOPY™ across approximately 2,000 OTP (Opioid Treatment Program) Clinics and other Addiction Treatment Center Networks in the United StatesAccording to IQVIA data
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Why Vicor Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Vicor shares surged 12% after raising Q3 growth guidance above 30%; Roze AI led gainers, while Corteva plunged 57% premarket.
Scienture Holdings (SCNX) Stock Drops 19% After Hours: Here's What Happened
Scienture Holdings shares tumble 19% after hours following a newly announced 1-for-25 reverse stock split.
Scienture Announces 1-For-25 Reverse Stock Split Effective On October 5, 2026